Use this newly updated Interactive Algorithm Tool to receive National Comprehensive Cancer Network® (NCCN®) guidance on optimal management of immune-related adverse events associated with immune checkpoint inhibitor therapy, adapted from the NCCN Guidelines for Management of Immunotherapy-Related Toxicities v1.2019.
Get expert insights on how the latest clinical data inform identification and management of challenging immune-related adverse events in patients with cancer who are receiving immune checkpoint inhibitors.
Use this interactive tool to easily access NCCN Guidelines on management of irAEs for your specific patient scenarios.
Checkpoint inhibitors come with a unique array of immune-related adverse events, which nurses can struggle to manage effectively and which concern patients. Read my thoughts on managing these adverse events and discussing them with patients.
In this downloadable slideset, review expert insights and recommendations from NCCN Guidelines on identification and management of immune-related adverse events associated with immune checkpoint inhibitor therapy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.